Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo  >  Chugai Pharmaceutical Co Ltd    4519   JP3519400000

CHUGAI PHARMACEUTICAL CO LTD

(4519)
My previous session
Most popular
  Report  
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Chugai Pharmaceutical : Releases Disease Awareness Anime about Rheumatoid Arthritis in Multiple Languages Emphasizing Importance of Early Detection/Treatment and Care by Specialists

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/12/2018 | 12:31am EST

-- Starring Comedienne Kayoko Ohkubo and Voice Actress Ayana Taketatsu --

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that it released a disease awareness anime about rheumatoid arthritis dubbed in English and subtitled in Chinese, Korean, French and Spanish, celebrating World Arthritis Day on October 12.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181011005989/en/

(Graphic: Business Wire)

(Graphic: Business Wire)

Rheumatoid arthritis is an autoimmune disease that most commonly develops in women aged from 30 to 59. The number of patients is estimated to be 0.7 million in Japan and 23 million in the world*. The disease causes destruction of the joints and bones and deformation of hands and feet, which may significantly affect daily lives. However, with recent treatment advances an increasing number of people with the disease can control joint swelling and pain, as well as continue daily activities like housekeeping and hobbies, if they visit specialized medical centers early and receive appropriate treatment.
*Report by Study Committee on Rheumatoid Arthritis and Allergy; (http://www.mhlw.go.jp/stf/houdou/2r9852000001nfao-att/2r9852000001nfdx.pdf) and WHO Global Burden of Disease Report (table 7, page 32) 2004; (http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf)

Chugai has continuously emphasized the importance of early treatment of rheumatoid arthritis and promoted a better understanding through a short film titled “Mother’s Lipstick” (awarded 2016 Cannes Lions Bronze) and a music video titled “With A Wish” released by a singer, Mina Ganaha.

Under the concept of “contribute to the medical community and people’s health around the world by expanding awareness of rheumatoid arthritis among the general public as well as patients and their families,” we have decided to release a disease awareness film by means of anime, one of the icons of Japanese culture. With this movie, we aim to appeal to a broad age range, including the younger generation aged between 10 to 29, about the importance of “early detection”, “early treatment” and “medical care provided by rheumatologists”.

Tatsunoko Production Co., Ltd., a company that has introduced Japan’s leading anime series including “Yatterman” and “The Genie Family” throughout the world, was responsible for character design and production. Ayana Taketatsu, a voice actress who has over one million followers on Twitter, and Kayoko Ohkubo, a comedienne who herself has experienced rheumatoid arthritis, voiced the main characters.

Chugai is continuously committed to promoting disease awareness activities leading to trust and appreciation from all stakeholders including patients, their families, and healthcare professionals, aiming at contributing to the medical community and people’s health around the world.

● A Summary of the Rheumatoid Arthritis Awareness Animation

[Title]   Disease Awareness Anime on Rheumatoid Arthritis, “Magic Glasses” (6 minutes and 55 seconds)
[Released on] Videos & Advertisements in Chugai Pharmaceutical’s corporate website

https://www.chugai-pharm.co.jp/english/profile/ad/index.html

Chugai Pharmaceutical’s YouTube official channel

https://www.youtube.com/user/chugaijp

 

[Story]     Nanami and Hikaru have grown up together on an island. They were spending happy and cheerful days. It happened on one of those days when Nanami was a senior in high school. Nanami’s mother started to complain of discomfort of the hands and fingers. Nanami was worried about her mother and took her to a hospital. The symptoms, however, did not improve. Hikaru was determined to become a doctor to help Nanami and her mother suffering from the unexplained symptoms. After becoming a medical student, Hikaru studied hard and encouraged Nanami’s mother to consult a rheumatologist. Nanami was relieved seeing her mother successfully started treatment of rheumatoid arthritis. In fact, Hikaru helped Nanami because he had certain thoughts.
 

[Voice Actors/Actresses (Cast)]

Character   Cast
Nanami Ayana Taketatsu / voice actress, singer, and narrator
Hikaru Miyu Irino / voice actor and singer
Minami Kayoko Ohkubo / comedienne (Oasiz)
Nozomi   Mizuha Kuraoka / pop star (22/7)
 

About Chugai

Chugai Pharmaceutical is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Chugai, based in Tokyo, specializes in prescription pharmaceuticals and is listed on the 1st section of the Tokyo Stock Exchange. As an important member of the Roche Group, Chugai is actively involved in R&D activities in Japan and abroad. Specifically, Chugai is working to develop innovative products which may satisfy the unmet medical needs, mainly focusing on the oncology area.
In Japan, Chugai’s research facilities in Gotemba and Kamakura are collaborating to develop new pharmaceuticals and laboratories in Ukima are conducting research for technology development for industrial production. Overseas, Chugai Pharmabody Research based in Singapore is engaged in research focusing on the generation of novel antibody drugs by utilizing Chugai’s proprietary innovative antibody engineering technologies. Chugai Pharma USA and Chugai Pharma Europe are engaged in clinical development activities in the United States and Europe.
The consolidated revenue in 2017 of Chugai totalled 534.2 billion yen and the operating income was 103.2 billion yen (IFRS Core basis).
Additional information is available on the internet at https://www.chugai-pharm.co.jp/english.


© Business Wire 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CHUGAI PHARMACEUTICAL CO L
02/14CHUGAI PHARMACEUTICAL : Actemra, the World's First Anti-IL-6 Receptor Antibody C..
AQ
02/13CHUGAI PHARMACEUTICAL : Wins Second Prize in 21st NIKKEI Annual Report Awards
AQ
02/07CHUGAI PHARMACEUTICAL : Together with Roche, Chugai Joins the World Federation o..
AQ
02/06CHUGAI PHARMACEUTICAL : Together with Roche, Chugai Joins the World Federation o..
BU
02/04CHUGAI PHARMACEUTICAL : Hemlibra Gains Positive CHMP Opinion in Severe Hemophili..
AQ
02/03CHUGAI PHARMACEUTICAL : Hemlibra® Gains Positive CHMP Opinion in Severe Hemophil..
BU
02/01CHUGAI PHARMACEUTICAL : Notice of Distribution of Retained Earnings
AQ
02/01CHUGAI PHARMACEUTICAL : Announces 2018 Full Year Results and Forecasts for 2019
AQ
02/01CHUGAI PHARMACEUTICAL : Organizational and Personnel Changes
AQ
02/01CHUGAI PHARMACEUTICAL : Announces New Mission Statement and New Mid-Term Busines..
AQ
More news
Financials (JPY)
Sales 2019 617 B
EBIT 2019 -
Net income 2019 112 B
Finance 2019 242 B
Yield 2019 1,33%
P/E ratio 2019 35,34
P/E ratio 2020 29,91
EV / Sales 2019 6,37x
EV / Sales 2020 5,85x
Capitalization 4 170 B
Chart CHUGAI PHARMACEUTICAL CO LTD
Duration : Period :
Chugai Pharmaceutical Co Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHUGAI PHARMACEUTICAL CO L
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 6 763  JPY
Spread / Average Target -9,2%
EPS Revisions
Managers
NameTitle
Tatsuro Kosaka President, CEO & Representative Director
Osamu Nagayama Chairman
Itagaki Toshiaki CFO, Manager-Information Technology & Accounting
Hisafumi Okabe Senior Executive Officer & Head-Research
Hisanori Takanashi Manager-R&D Portfolio Management Department
Sector and Competitors
1st jan.Capitalization (M$)
CHUGAI PHARMACEUTICAL CO LTD20.55%37 669
JOHNSON & JOHNSON5.85%363 785
PFIZER-3.46%249 168
ROCHE HOLDING LTD.13.89%238 335
NOVARTIS8.12%231 565
MERCK AND COMPANY5.71%210 032